Related Experiment Video

Updated: Aug 11, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

The effects of blood pressure and lipid control on kidney allograft outcome

Jose-Marie El-Amm1, Abdolreza Haririan, Errol D Crook

  • 1Wayne State University School of Medicine, Detroit, Michigan, USA.

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|February 24, 2006
PubMed

Insights

Kidney transplant recipients with hypertension and hyperlipidemia face graft loss. Current guidelines for non-transplant patients on blood pressure and lipid targets are recommended post-transplant to improve outcomes.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Cardiovascular Medicine

Background:

  • Kidney allograft survival has improved, but chronic allograft nephropathy (CAN) and cardiovascular disease (CVD) remain significant causes of graft loss.
  • Hypertension and hyperlipidemia are increasingly recognized as key contributors to CAN and CVD progression in kidney transplant recipients.

Purpose of the Study:

  • To review the roles of hypertension and hyperlipidemia in kidney transplant outcomes.
  • To provide recommendations for managing blood pressure (BP) and serum lipids in kidney transplant recipients.

Main Methods:

  • Review of current evidence regarding hypertension, hyperlipidemia, and their impact on kidney allografts.
  • Analysis of existing guidelines for BP and lipid management in the general population.

Main Results:

  • Lack of large, randomized controlled trials specifically for kidney transplant recipients.
  • Available data suggest that target BP and lipid levels recommended for non-transplant patients may be applicable post-transplantation.

Conclusions:

  • Achieving target BP and lipid levels is crucial for improving kidney allograft and patient survival.
  • HMG-CoA reductase inhibitors may offer additional benefits beyond lipid lowering, potentially prolonging graft survival.

More Related Videos

Using a Chemical Biopsy for Graft Quality Assessment05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...